.png)
I’M MAD AS HELL AND I’M NOT GOING TO TAKE IT ANYMORE
(AND YOU SHOULD BE AS WELL!)
I asked Grok4: “How many COVID cases and COVID deaths could have been prevented with optimal D3K2?”
Dr. Fauci and the government could have prevented 8 million cases of COVID and 270,000 of the 300,000 COVID deaths while waiting for the mRNA vaccine. Dr Kaufman published a nationwide US study in 2020 at the beginning of the COVID pandemic. The study covered about 200,000 US patients. Their group found that people on optimal blood levels of D3 (over 50 ng/ml); had a 50% reduction in getting COVID. 95% of the US had suboptimal levels.
If the US (and the world) had been started on these safe, cheap (OTC; no Rx) levels; millions of lives could have been saved. Kaufman’s Study was an OBSERVATIONAL STUDY. Observational studies are not as good as randomized control studies (RCT); RCTs prove causation. The government started a RCT but used inactive D3. That study showed –NO BENEFIT; so they declined to recommend it. We have known for years that when sunshine hits your skin you make D3. However it takes your liver and kidneys 2 weeks to activate D3. The study used inactive D3. They either died or got better in those 2 weeks. Fauci may have been an expert in AIDS but was severely lacking in knowledge of D3 and COVID. All his team had to do was read the US and world research. I thought that was their job to be aware of current worldwide research. Dr Entrenas Castillo published a study in Spain (2020). They gave patients coming in to the ER with severe COVID activated D3 (cheap) and compared them to “routine” COVID care. They found a 96% reduction in the need for ICU and mechanical ventilation (2% vs 50% with no active D3). Active D3 had NO deaths (0%) vs 8% deaths in the control group. If you had not been taking optimal levels of D3 for at least 2 weeks before getting COVID; you did not have 2 weeks for your body to activate D3 and you died. Think of the millions of cases and deaths from COVID that could have been prevented if the government had immediately recommended the cheap ($0.13/ week; OTC) D3K2. Add a comment if you had a loved one that died from COVID. If their needless deaths don’t make you MAD AS HELL; I don’t know what will.
COVID has become like the flu but what about the next pandemic? It has been over 5 years and the government still has not done any RCT of D3K2. Write or call congress and the president. RCTs cost at least $10 million. Big Pharma will NEVER pay for a RCT of D3K2 because they cannot patent a vitamin; therefore no profit. They paid for the mRNA RCT; but they made trillions of dollars. They probably do not want a cheap OTC product that decreases their mRNA sales. The government is finally demanding long term RCT of mRNA vaccines to look for adverse effects (long COVID, heart and CVD damage, and premature death from the vaccine. They could require Big Pharma to randomize 50% of the controls and 50% of the MRNA groups with optimal levels of D3K2. That would save the government millions of dollars.
How to get optimal doses
· Either 50,000 IU D3 and 200 mcg K2 (combined in one pill taken once a week)
o $0.15/ pill (available on Amazon but not in most drug stores; Micro Nutrients)
· Or 10,000 IU D3 taken every day
· Both are safe (no adverse reactions worldwide) and way more effective than current government recommendations (800 IU/d).
· To reach blood levels of 50-100 ng/ml of D3 requires at least the 50,000/wk or the 10,000/d.
· Everyone should have their doctor check a D3 level at least once a year, especially if you are taking more.
· Your optimal blood D3 level should be 50-100 ng/ml;
o 95% of the US has suboptimal levels
· If you are outside near the equator (without sunscreen) your body will make these levels
o For everybody else we need the cheap OTC supplements to get optimal levels
o Nobody but Miami nudist members get these levels in the winter
§ That is one reason why cold and flu season is during the winter (D3 levels are the lowest)
· See all my books on Amazon:
o https://www.amazon.com/Secrets-Vitamins-That-Save-your/dp/B0DXCGD5GW
Unnecessary Flu and COVID Deaths?
· Still after 5 years of government inaction;
o No Large RCTs to once and forever prove D3K2 saves lives
Your Only Choice At This Point (Until governments get off their Butts)
· Multiple studies from 2020 showed a dramatic decrease in cases and deaths from COVID for people on optimal doses of D3K2 (50-100 ng/ml D3) ;
o Only 5% of Americans had optimal D3 levels
o Estimated 8 million cases of COVID could have been prevented
o You need 10,000 IU of D3/d or 50,000 IU D3/wk (forever) to maintain optimal levels
§ Not available at local drug stores
§ Available on Amazon (microNutrients; $0.15/wk)
§ Safe (no adverse effects)
§ Have your doctor check a D3 level every year
§ Send your doctor a copy of my book (proven EBM)
· https://www.amazon.com/Secrets-Vitamins-That-Save-your/dp/B0DXCGD5GW
· If you have severe COVID/Flu (hospital) and have not been taking D3; request your doctor give you Calcifediol (activated D3)
o It takes your body 2 weeks to activate D3 to Calcifediol; you do not want to die while waiting for your body to activate D3
o During the COVID pandemic the government tried inactive D3---No decrease in deaths
o Spanish doctors used Calcifediol (activated D3) on admission to the hospital and reduced ICU admissions and deaths by 80+ %
Grok:
· What is the most common flu strain currently circulating in the US;
· Number of deaths?;
· Is it in this year’s flu vaccine?;
· If not, any benefit for prevention compared to no vaccine?
· Most Common Flu Strain Currently Circulating in the US Based on the latest CDC surveillance data through late February 2026,
o The predominant influenza strain circulating in the US during the 2025-2026 season is influenza A(H3N2),
o Accounting for approximately 88-90% of reported cases.
o More specifically, over 90% of these H3N2 viruses belong to a variant known as subclade K, which emerged in mid-2025 and has driven the majority of infections.
This strain has been associated with higher-than-usual hospitalization rates, particularly among children, and has contributed to a moderately severe season overall.
Number of Deaths
· As of the week ending February 21, 2026 (the most recent comprehensive estimate available), the CDC reports approximately
o 20,000 influenza-associated deaths in the US for the 2025-2026 season.
o This includes 79 pediatric deaths reported to date.
Earlier estimates from January 2026 placed the figure around 10,000 deaths, indicating a continued rise as the season progressed.
These numbers are preliminary and may increase as more data are reported, but they reflect a higher burden compared to milder recent seasons. For context, the prior 2024-2025 season saw an estimated 45,000 total deaths, which was classified as high severity.
The current season's mortality is driven largely by the dominance of H3N2 subclade K and elevated hospitalization rates (estimated at 330,000 so far).
Is It in This Year's Flu Vaccine?
The 2025-2026 US influenza vaccines are trivalent, formulated to protect against three strains: an A(H1N1)pdm09-like virus, an A(H3N2)-like virus, and a B/Victoria lineage virus. Specifically:
-
Egg-based vaccines target an A/Croatia/10136RV/2023 (H3N2)-like virus.
-
Cell- or recombinant-based vaccines target an A/District of Columbia/27/2023 (H3N2)-like virus.
The circulating H3N2 subclade K variant is not a direct match to these vaccine strains, as it emerged after the vaccine composition was finalized in early 2025 (first detected in June 2025).
This mismatch may reduce the vaccine's effectiveness against this specific variant.
Benefits for Prevention Compared to No Vaccine.
Even with the mismatch, receiving the 2025-2026 flu vaccine still offers meaningful benefits compared to no vaccination. It can provide cross-protection against severe outcomes from H3N2 subclade K, reducing the risk of hospitalization and death by mitigating illness severity. Studies from similar mismatched seasons show vaccines can prevent 20-60% of hospitalizations in adults and children, depending on age and health status.
For high-risk groups like older adults or those with comorbidities, the benefits in preventing complications outweigh the imperfect match. Vaccination remains recommended for all eligible individuals, as it contributes to overall community protection and reduces healthcare burden.
Vaccine Effectiveness Studies
COVID-19; Flu Interactions
Any studies looking at optimal D3 (50-100 ng/ml) for preventing influenza A(H3N2) subclade K;
· Or using calcifediol on admission to hospital/ICU to prevent deaths?
· NONE
Does Tamiflu work?
Studies on Optimal Vitamin D3 Levels (50-100 ng/ml) for Preventing Influenza A(H3N2) Subclade K?
No studies were identified that specifically examine Vitamin D3 levels for preventing infections with the H3N2 subclade K variant, which emerged in mid-2025 and has driven the majority of cases in the 2025-2026 US flu season. This is likely due to its recent appearance, limiting time for targeted research.
However, multiple meta-analyses and observational studies on Vitamin D and influenza A (including H3N2 strains) suggest that higher serum 25(OH)D levels (often in the 40-60 ng/ml range or above) may reduce the risk of acute respiratory infections (ARIs), including flu, particularly in those with baseline deficiency.
Key findings include:
-
A 2020 meta-analysis of observational studies and trials found that Vitamin D supplementation reduced influenza risk, with optimal 25(OH)D levels of 40-60 ng/ml (100-150 nmol/L) associated with the greatest protection.
Supplementation (e.g., 10,000 IU/day initially, then 5,000 IU/day) was recommended to achieve these levels quickly.
-
A 2025 meta-analysis of 37 RCTs showed a modest overall reduction in ARI risk (OR 0.92, 95% CI 0.86-0.99), with stronger effects in deficient individuals (25(OH)D <25 nmol/L, or 10 ng/ml).
-
A 2024 observational study of 12,605 adults showed a 43% lower risk of flu-like illness at >=60 ng/ml compared to <20 ng/ml (P<0.0001), with a dose-response decrease starting at >=40 ng/ml.
-
A 2022 meta-analysis of 10 RCTs (n=4859) reported that Vitamin D supplementation reduced influenza risk by 22% (RR 0.78, 95% CI 0.64-0.95), independent of baseline levels, though effects were inconsistent across trials.
The 50-100 ng/ml D3 range aligns with suggested optima in some studies (e.g., 40-60 ng/ml), but routine supplementation isn't universally recommended
Future research on subclade K could clarify strain-specific effects.
Studies Using Calcifediol on Admission to Hospital/ICU for Influenza
· No studies were found specifically evaluating calcifediol (25-hydroxyvitamin D) for influenza treatment upon hospital or ICU admission.
· Searches yielded results primarily on COVID-19, where calcifediol has shown benefits in reducing severity.
· This may reflect its use for rapid Vitamin D repletion in acute settings, but evidence for flu is lacking.
Extrapolating from COVID data:
A 2025 retrospective study (n=230 COVID-19 patients) found calcifediol reduced mortality (12.6% vs. higher in untreated, OR not specified).
o A 2021 cohort (n=537) reported lower in-hospital mortality with calcifediol (adjusted OR 0.66, 95% CI 0.46-0.96).
o A 2022 review noted reduced mortality risk (OR 0.21, 95% CI 0.10-0.43); 80% reduction in deaths with admission to the hospital calcifediol.
o A 2020 pilot RCT (n=76) found calcifediol (0.532 mg on admission, then 0.266 mg on days 3/7)
§ Reduced ICU admission (2% vs. 50%, OR 0.03, 95% CI 0.003-0.25)
§ And mortality (0% vs. 8%).
o But flu-specific RCTs are needed.
· Does Tamiflu (Oseltamivir) Work Against Influenza A(H3N2) Subclade K?
o Yes, Tamiflu is effective against H3N2 subclade K, with no evidence of resistance.